01 February 2022 | Views
HEL, a global developer and manufacturer of innovative laboratory tools for process optimisation, safety, and scale-up, announced the appointment of Rajeev Kumria as General Manager, HEL India. The announcement follows the recent news that HEL is expanding operations in India by moving to a wholly-owned subsidiary in the country. Kumria reveals more about India plans
How do you foresee the Indian market in terms of the growth of your business?
Our decision to move to a direct entity in India is directly due to the growth potential. We've seen very encouraging performance through our distributor in the country recently. When this is coupled with India's macro trends and market conditions, we feel this will become a rapidly growing region. Science and technology are huge growth sectors in India – coupling the core of fine chemicals and pharmaceuticals with the growing biotechnology industries and battery development technology, we see a very strong fit between our capabilities and the Indian market needs.
What are the new offerings in the innovative laboratory tools space for the biotech & pharma industries?
We feel that there are three areas where we can bring significant impact to the marketing in India for biotech and pharma
How much is being invested in opening facilities in India?
That's a topic that we keep under constant review in the highly changeable world we live in post-COVID.
What are your plans in terms of hiring new talent in India wrt to biotech and pharma expertise?
Our focus will be on the right facilities and continuing to build up a team that focuses on the customer. My appointment is the first step – with my experience across a broad range of scientific companies being an accelerator to our growth. Our current customers should also feel reassured about the continuity of support during this transition period. We have experienced service and support engineers who have been working in India for many years, and they are staying with the business in our new HEL owned entity.
Are you planning to invest in new technologies such as AI, ML etc. within the Indian facility?
We are a global technology company. It isn't easy to pinpoint technologies to one specific location or geography. Our strengths lie in hardware and software that allows researchers to work with demanding and potentially dangerous applications safely. What drives us isn't the specific inclusion of technology like artificial intelligence, virtual reality, etc. As you might expect, we continue to review the technology landscape and include approaches that support our broader aims.
Tell us about the company's growth plans for the next five years in India?
Of immediate focus is making sure that we continue to support our existing customers in India while building up our new business. Our longer-term strategy is to scale up our operations in India, such that it is one of the major geographies for the H.E.L Group. It's fair to say that no options are on or off the table at this point, but like many businesses, the last two years have taught us to remain agile with our plans, as the world can suddenly change around us. We will continue to focus on making the world healthier, safer, and more sustainable for everyone.